SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-341046
Filing Date
2017-11-13
Accepted
2017-11-13 16:56:58
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d493039ds3.htm S-3 391601
2 EX-4.1 d493039dex41.htm EX-4.1 318013
3 EX-4.3 d493039dex43.htm EX-4.3 114798
4 EX-4.4 d493039dex44.htm EX-4.4 113911
5 EX-4.5 d493039dex45.htm EX-4.5 102380
6 EX-5.1 d493039dex51.htm EX-5.1 11724
7 EX-5.2 d493039dex52.htm EX-5.2 19835
8 EX-23.1 d493039dex231.htm EX-23.1 1597
9 GRAPHIC g493039g44y37.jpg GRAPHIC 34869
10 GRAPHIC g493039g64x53.jpg GRAPHIC 4343
  Complete submission text file 0001193125-17-341046.txt   1129104
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-221526 | Film No.: 171196772
SIC: 2834 Pharmaceutical Preparations